Randomized trial comparing dose reduction and growth factor supplementation for management of hematological side effects in HIV/hepatitis C virus patients receiving pegylated-interferon and ribavirin
Andrew H. Talal, Ruei Chi Liu, Marija Zeremski, Rositsa Dimova, Lorna Dove, Daniel Pearce, Tarek Hassanein, Leleka Doonquah, David Aboulafia, Jorge Rodriguez, Hector Bonilla, Jeffrey Galpin, Judy A. Aberg, Barbara Johnston, Marshall J. Glesby, Ira M. Jacobson
Research output: Contribution to journal › Article › peer-review
10Scopus
citations
Fingerprint
Dive into the research topics of 'Randomized trial comparing dose reduction and growth factor supplementation for management of hematological side effects in HIV/hepatitis C virus patients receiving pegylated-interferon and ribavirin'. Together they form a unique fingerprint.